Shock wave therapy ineffective in treatment of lateral epicondylitis .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Extracorporeal shock wave therapy in the treatment of lateral epicondylitis : a randomized multicenter trial.
J Bone Joint Surg Am. 2002 Nov;84-A(11):1982-91272 patients with lateral epicondylitis who did not respond to at least 6 months of conservative treatment were treated with local anesthesia. They were then randomized to extracorporeal shock wave therapy with three treatments of 2000 pulses each or to placebo treatment. The primary outcome was rate of success (based on the Roles and Maudsley score and need for additional treatment) at 12 weeks. Other outcomes were the Roles and Maudsley score, subjective pain rating, and grip strength through 12 months. Success rates were similar between the two groups and there were no significant differences between groups for the other outcomes. Two-thirds of patients in both groups showed improvement at 12 months.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics